bevacizumab-bvzr

CHEBI:CHEBI_755359

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2268048
product_type
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
LIQUID
route
INTRAVENOUS
marketing_category
BULK INGREDIENT
marketing_start_date
20200113
labeler_name
SAMSUNG BIOLOGICS Co., Ltd.
manufacturer_name
Pfizer Laboratories Div Pfizer Inc
active_ingredient_strength
16 kg/16kg
nui
N0000178291
pharm_class_epc
Vascular Endothelial Growth Factor Inhibitor [EPC]
pharm_class
Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
pharm_class_moa
Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
package_marketing_start_date
23-JUN-23
active_ingredient_name
BEVACIZUMAB-BVZR
unii
2S9ZZM9Q9V
generic_name
bevacizumab-bvzr
brand_name
Zirabev
brand_name_base
Zirabev
product_ndc
0069-0342
application_number
BLA761099
spl_id
042c8e3d-add1-67da-e063-6294a90ada4a
package_ndc
0069-0342-01
package_description
1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1 VIAL, SINGLE-USE
spl_set_id
aa27acbd-d117-4350-aeee-17bc2e2c0ca4
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class